Online "Pain, Stress & Emotions" Class in Chronic Pain

November 4, 2024 updated by: Maisa Ziadni, Stanford University

Online "Pain, Stress & Emotions" Class in Chronic Pain: Single-arm Efficacy Test

Members with chronic pain will be invited to participate in a 2-hour zoom-delivered pain psychology class entitled "Pain, Stress, & Emotions". Surveys are completed at baseline (prior to the online class), a satisfaction survey is completed after the class, and post-treatment surveys completed 2, 4, 8, and 12 1weeks after class attendance.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Chronic pain condition (pain > 3 months)
  • Access to the internet
  • English fluency

Exclusion Criteria:

  • Ongoing legal action or disability claim
  • Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pain, Stress, & Emotions Class
No active or placebo comparator will be used. This is a single-arm study design.
2-hour, zoom-delivered, group intervention focused on teaching patients how pain is processed in their brain and learning about the role of psychosocial factors in their pain conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity NRS
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Self-reported pain intensity rating
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcomes Measurement Information System: Pain Interference short form 6a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported pain interference levels
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: Depression 6a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported depression
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: Anxiety 6a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported anxiety
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: Physical Function 8b
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported physical functioning
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: Sleep Disturbance 6a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported sleep disturbance
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: social isolation 6a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported social isolation
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: fatigue 6a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported fatigue
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Patient-Reported Outcomes Measurement Information System: anger 5a
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported anger
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Ambivalence over Emotional Expression (AEQ)
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
self-reported ambivalence levels about emotional expression
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Emotion-Approach Coping
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
8-item emotion approach coping scale
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Pain Bothersomeness
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
single-item assessing self-reported levels of pain bothersomeness
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Attributions Questionnaires
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Two self-report questionnaires were developed to assess psychological and brain influences on pain. The 4-item psychological attribution scale assesses patients' beliefs that their thoughts and feelings and psychological therapy impacts pain, and the 3-item brain attribution scale assesses patient's beliefs that their pain is brain-based. Mean scores will be computed for both scales separately (0-4; higher scores indicating greater belief that pain is a brain-related [brain attribution] construct and that pain is affected by thoughts, feelings, and psychological interventions [psychological attribution])
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Pain Catastrophizing Scores; measured with Pain Catastrophizing Scale
Time Frame: Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)
Pain Catastrophizing Scale (Sullivan et al., 1995): A summed score of the 13 catastrophizing items will be computed (0-52, higher scores indicate greater catastrophizing)
Change from baseline to 1-Month follow-up (with secondary 2-month follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2021

Primary Completion (Actual)

January 15, 2022

Study Completion (Actual)

March 20, 2022

Study Registration Dates

First Submitted

August 12, 2021

First Submitted That Met QC Criteria

August 18, 2021

First Posted (Actual)

August 20, 2021

Study Record Updates

Last Update Posted (Estimated)

November 5, 2024

Last Update Submitted That Met QC Criteria

November 4, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • StanfordClass

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Pain, Stress and Emotions

Subscribe